Catalio Capital Management was created by George Petrocheilos and Dr. Jacob Vogelstein to invest in breakthrough biomedical technology companies created or referred by Catalio Capital Management, an elite group of world-renowned, serial scientist-entrepreneurs.  

Hyperfine

ATAI Life Sciences

Sensei Biotherapeutics

Personal Genome Diagnostics

Recursion Pharmaceuticals

Catalio Capital Management

Catalio Capital is inferred to be a financial services firm that likely specializes in investment management, capital allocation, and financial advisory services.

COM:CATALIOCAPITAL

Catalio Capital

Filings Not Available